AIBL Archives - Australian Alzheimer's Research FoundationAustralian Alzheimer's Research Foundation

Home > Posts Tagged "AIBL"

September 22nd, 2023

Join Us for an Exclusive Discussion on Sleep and Brain Health

Join CogSleep and the Australian Alzheimer's Research Foundation, in partnership with researchers from Murdoch, Macquarie, Edith Cowan University, and the University of Sydney, for a thought-provoking discussion on the topic of "How do you ensure a...

August 31st, 2023

World Alzheimer’s Month

September is World Alzheimer's Month World Alzheimer’s Month is an international event held every September to raise awareness and challenge stigma surrounding Alzheimer’s and dementia. September 21st is World Alzheimer’s Day. Our Septem...

August 11th, 2023

2023 Public Lecture

Curious about the realm of Alzheimer's research? Have you witnessed the impact of this condition that touches the lives of millions of people worldwide, or perhaps it has touched you personally within your own family? Regardless of your connectio...

August 7th, 2023

Good sleep is essential for brain health

Improve your sleep to help combat Alzheimer's Making changes to your sleep routine could play an important role in delaying and preventing the symptoms of Alzheimer’s disease and other dementias, according to Associate Professor Stephanie ...

July 24th, 2023

Have you had a ‘senior moment’?

Have you experienced a ‘senior moment’? Older adults can often be frustrated by little lapses in memory… things like forgetting where you put the car keys, or having trouble thinking of a word. Sometimes the forgetful moments might have mo...

July 17th, 2023

PROPOSED NEW DIAGNOSTIC CRITERIA UNVEILED AT AAIC 2023

International Conference on Dementia and Alzheimer's disease The Alzheimer’s Association International Conference (AAIC) kicks off this week in Netherlands. More than 10,000 of the brightest minds in dementia science will convene in Amsterd...

July 13th, 2023

Exercise for Brain Health

Exercise for improved brain health Take a ride on your bike, lift some weights, join a gym… it’s easy to add regular aerobic exercise and resistance training to your lifestyle. And it’s been shown that changing aspects of your life s...

July 10th, 2023

Breakthrough FDA Approval for New Drug

The drug Lecanemab has received full approval from the U.S. Food and Drug Administration (FDA) on the 6th of July 2023 This is the first treatment to receive full approval from the agency to help slow the progression of Alzheimer’...

June 26th, 2023

Leon Pericles – Member of the Order of Australia (AM)

Leon Pericles has been honoured with the appointment as a Member (AM) of the Order of Australia as part of The King's Birthday Honours 2023. The award is for his significant service to the visual arts, particularly to printmaking. Leon's career has ...

June 14th, 2023

AIBL – Still going strong!

Still going strong! Since 2006, the Australian Imaging, Biomarkers and Lifestyle Study (AIBL) has been uniting Alzheimer’s researchers across Australia. That’s 16 years of commitment! AIBL is at the forefront of Alzheimer’s disease research...

April 17th, 2023

Australian First!

Recently, the first participant in Australia was successfully screened for the ENVISION study at the Australian Alzheimer’s Research Foundation. The Phase 3b/4 Biogen ENVISION study is testing the drug Aduhelm (aka Aducanumab), which is a new a...

April 17th, 2023

Is it possible to modify your risk of dementia?

As world leaders, the Australian Alzheimer’s Research Foundation is involved in collaborative research across the globe, working with organisations to follow our vision – a world in which Alzheimer’s no longer exists. Preventing Dementia is...

April 13th, 2023

Research Roundup: A low-cost blood test to diagnose Alzheimer’s disease before symptoms appear

New research has shown the potential to diagnose the risk of developing Alzheimer’s disease ten years before symptoms appear, providing a window of opportunity to potentially change the trajectory of the disease. The Australian Alzheimer’s Re...

April 4th, 2023

Newsletter Now Available

Our latest issue of "Brainwave" is now available on our website. Don't miss out on some amazing articles, including a game-changing discovery - the potential to diagnose the risk of developing Alzheimer's disease a decade before symptoms appear! ...

March 28th, 2023

A Song To Say I Love You

Music from the heart... When Ben Walker’s mother Brenda was diagnosed with Alzheimer’s disease, it was a shock to the whole family. After having trouble with her peripheral vision, Brenda had a series of tests and was eventually diagnosed wit...

February 17th, 2023

HBF Run for a Reason 2023

JOIN OUR REASON To support research that we hope will one day make Alzheimer's disease treatable and preventable. You can walk, jog, run, and wheel for the Australian Alzheimer's Research Foundation! Make your mark, decide your distance, and ...

August 17th, 2022

Australian Alzheimer’s Research Foundation Public Lecture 2022

Thank you again to all of the speakers who shared their research work and insights with us. - A/Prof. Stephanie Rainey-Smith from Murdoch University - A/Prof. Hamid Sohrabi from Murdoch University - A/Prof. Belinda Brown from Murdoch University -...

May 5th, 2022

8 June 2022 – Annual General Meeting

8 June 2022 - Annual General Meeting Please join us for a wonderful afternoon with Maggie Beer AO and Ralph Martins AO We are delighted to host an event with celebrity chef and advocate for ageing well, Maggie Beer AO, together with internationa...

July 29th, 2021

Public Lecture 2021

Join the Australian Alzheimer's Research Foundation and researchers from Edith Cowan University and Murdoch University to hear the latest on Alzheimer's disease research and strategies you can implement to potentially reduce your risk of developin...

June 22nd, 2021

Drug for treatment of early stages of Alzheimer’s disease approved in U.S.

Aducanumab, a new drug to treat Alzheimer’s disease was recently given accelerated approval by the United States Food and Drug Administration. Developed by the US biotechnology company Biogen, aducanumab which will be commercially known as Aduhe...

January 13th, 2021

DONATE YOUR CONTAINERS!

In late 2020, Containers for Change launched in Western Australia. Containers for Change is a new state wide container deposit scheme that lets you cash in eligible containers for 10 cents each. In WA, we use more than 1.3 billion eligible ...

December 9th, 2020

Alzheimer’s patients wanted for new ATH-1017 LIFT-AD Study

Patients with mild-to-moderate Alzheimer’s disease and their carers living in Perth, are wanted for a clinical trial of a novel drug treatment that targets memory decline. ATH-1017 developed by Athira Pharma represents a new approach to treat Al...

November 19th, 2020

Congratulations Professor Martins!

Today, researchers across the world eagerly anticipated the release of the Highly Cited Researchers list for 2020. This list identifies global research scientists and social scientists who have demonstrated exceptional influence – reflected throug...

August 24th, 2020

World Alzheimer’s Month Webinars

During world Alzheimer’s Month, the Australian Alzheimer’s Research Foundation will be providing free weekly webinars to bring awareness to Alzheimer’s disease and the research work that will hopefully provide a better future for those at ri...

July 9th, 2020

BIOGEN COMPLETES APPLICATION TO FDA FOR ADUCANUMAB AS A TREATMENT FOR ALZHEIMER’S DISEASE

Biogen and Eisai today announced that Biogen has completed the submission of a Biologics License Application (BLA) to the U.S. Food and Drug Administration (FDA) for the approval of aducanumab, an investigational treatment for Alzheimer’s disease. ...

July 7th, 2020

THE PERSONAL IMPACT – Caroline’s story

Caroline is a clinical trial participant at the Australian Alzheimer’s Research Foundation. A former nurse who, during her career, used to take care of people with Alzheimer’s disease. About 5 years ago Caroline knew she was having tro...

June 18th, 2020

Meet our new Chairman – Graeme Prior

The Australian Alzheimer’s Research Foundation is delighted to announce that Mr Graeme Prior has accepted the role of AARF Chairman having joined the Board in 2019. “I am delighted to take on the role as Chair...

June 4th, 2020

Congratulations Stephanie!

Congratulations to Senior Research Fellow, Dr Stephanie Rainey-Smith who has been awarded a prestigious Investigator Grant by the National Health and Medical Research Council (NHMRC) for her research into healthy ageing. Dr Rainey-Smith will use t...

May 5th, 2020

The Personal Impact – Mel’s Story

Mother’s Day is a time for us to pay tribute to Mother’s and say thank you for their love and contribution to our society. It is a sad reality that Alzheimer’s disease is the leading cause of death in Australian women, and women also account...

May 1st, 2020

Brainwave Newsletter – April 2020

The latest edition of our newsletter ‘Brainwave’ is now available to download. If you would like to receive the Foundation’s newsletter to find out more about Alzheimer’s disease research sign up to our mailing list here....

April 14th, 2020

2019 Annual Report

Australian Alzheimer's Research Foundation Annual Report The Australian Alzheimer's Research Foundation 2019 Annual Report provides information about our achievements and impact and how we worked towards our vision of an Alzheimer's free future in t...

March 26th, 2020

Keeping our facilities safe – An update on COVID-19

Keeping our facilities safe - an update on COVID-19 Providing a safe and supportive environment for our staff, trial participants and their families is paramount and our absolute priority. It is important you do not come into the Fou...

February 19th, 2020

2020-2021 Entertainment Memberships

Support Australian Alzheimer's Research Foundation –Purchase your NEW 2020|2021 Entertainment™ Digital Membership HERE Get access to hundreds of valuable offers for everything you love to do and support Alzheimer's Research at t...

February 13th, 2020

The link between low testosterone levels in men and a deterioration of the brain.

Professor Ralph Martins recently took part in an ABC Radio interview to talk about the link between Alzheimer's and Testosterone. ...

February 3rd, 2020

Could boost testosterone delay dementia in men?

Taking testosterone supplements can boost men's brain health into old age, a new research review has found. Researchers from Edith Cowan University analysed the results of previous randomised control trials that examined if taking testosterone suppl...

January 23rd, 2020

Effects of Testosterone Supplementation on Separate Cognitive Domains in Cognitively Healthy Older Men

Researchers from Edith Cowan University have recently analysed the results of previous randomised control trials that examined if taking testosterone supplements improved cognitive function in older men. The evidence shows that testosterone suppleme...

January 22nd, 2020

Avoiding Alzheimer’s – Dr Rainey-Smith

Despite the efforts of researchers worldwide, a cure for Alzheimer’s disease remains elusive. But one area where researchers have made great strides has been identifying the role lifestyle factors, such as diet, exercise and sleep, can play in r...

December 13th, 2019

Who will you remember this Christmas?

Christmas is that time of year when families and friends come together to celebrate and make special memories to treasure forever. Sadly, Alzheimer’s and other forms of dementia are stealing those memories. It can affect anyone. It can affect you o...

October 24th, 2019

BIOGEN PLANS REGULATORY FILING FOR ADUCANUMAB IN ALZHEIMER’S DISEASE BASED ON NEW ANALYSIS OF LARGER DATASET FROM PHASE 3 STUDIES

Some very encouraging news for the treatment of Alzheimer’s. Biogen Inc. announced it will seek U.S. Food and Drug Administration (FDA) approval in early 2020 for the experimental drug aducanumab after study results showed it reduced clinical d...

October 7th, 2019

Congratulations Professor Ralph Martins

Congratulations to Professor Ralph Martins who has been awarded a $3.1 million dollar grant as part of the Federal Government’s $8 million for ground-breaking clinical trials. The study called AU-ARROW (AUstralian-multidomain Approach to Reduce ...